Peninsula Square
London
SE10 0DX
United Kingdom
- Progress in Molecular and Cellular Pathology
- Developments in immunohistochemistry for diagnostic cellular pathology
- Biomarkers
- Histopathology and Cytopathology: Advances in research and techniques
With plenty of opportunity for networking and debate, this informal international meeting will bring you up to date with current research and thinking regarding pathology. This meeting gathers together workings from clinical, academic and pharmaceutical organisations.
This event has CPD accreditation
This event has an open oral and poster session. Abstracts can be submitted on any subject related to pathology
Who Should Attend
All who need to be at the leading edge of developments in this area will find this attendance at this conference rewarding. Attendance is recommended to both professionals and students within the diagnostic and research communities that engage with pathology.
This session will discuss current topics presented by experts in their fields of research and practice. Placed in the context of molecular cellular pathology presentations will explore disease mechanisms, clinical advances and latest technology breakthroughs.Day 2: Developments in immunohistochemistry for diagnostic cellular pathology Developments in Immunohistochemistry (IHC) techniques and technology to aid the improvements needed to boost and strengthen the use of IHC in future diagnostic pathology practice will be discussed
Day 3:
Pediatric Liver Tumors. Pearls and Pitfalls: Professor Consolato Sergi, Professor of Pathology and Adj. Professor of Pediatrics, University of Alberta, Canada
Update in the molecular pathology of uveal melanoma: Professor Sarah Coupland, Professor and Honorary Consultant in Pathology, University of Liverpool, UK
Dr Niccola Funel, University of Pisa, Division of Surgical Pathology, Pisa, Italy
Emerging role of the pathologist and cancer biomarking in as applied to stratified medicine and targeted therapy: Professor Bharat Jasani, Cardiff University School of Medicine, Institute of Cancer & Genetics, UK
Quantifying digital pathology in a large human brain cohort: Dr Atticus H Hainsworth se, Stroke & Dementia Research Centre, St George’s University of London, UK
Chromogranin A- immunoreactive cells as a biomarker in the diagnosis of irritable bowel syndrome and lymphocytic colitis: Professor Magdy El-Salhy, Stord Hospital, Dept. of Clinical Medicine, Bergen University, Norway
Application of the Nanotechnology in Immunohistochemical Staining Procedures: Dr Weiming Xu, CEO London Biotech Ltd and Department of Molecular Biology and Biotechnology, University of Sheffield, UK
Companion diagnostic tests for targeted cancer treatment: advances and challenges: Professor Yao-Shan Fan,University of Miami Miller School of Medicine, Florida, USA
Molecular expression profiles of different types of thyroid carcinomas: Dr. Monika Lamba Saini, Université catholique de Louvain, Brussels, Belgium
Diagnosing vitamin B12 deficiency using static and functional markers: Dr Agata Sobczyńska, St. Thomas’ Hospital, London, UK
Screening Serum Biomarkers on Cancer Patients: Using Mass Spectrometry to Answer Clinical Questions: Professor Aline M.A. Martins, Brazil
Histopathologic diagnosis in the era of new and old yeast infections in critical ill surgical patients: Assistant Professor Paola Di Carlo, Department of Sciences for Health Promotion and Mother-Child Care, University of Palermo, Italy
Role of cytopathology in steering targeted therapies in lung oncology patients: Dr Harman Sekhon, University of Ottawa, Ontario, Canada
From Eustachius to Schuknecht: What have human temporal bone pathology studies taught us: Dr. Panos Dimitriadis, Luton and Dunstable Hospital, UK
Additional confirmed Speakers
- Speaker to be confirmed, Advanced Cell Diagnostics, Inc
- Fiona Marshall, Promega
- Dr SuEllen Pommier, Associate Professor, Oregon Health & Science University, USA
- Dr Sterghios A. Moschos, Westminster Univerity, London, UK
